Prophylactic Cranial Irradiation in Limited Stage Small Cell Lung Cancer: Survival Benefit in Patients with Favourable Characteristics

By The Aarhus Lung Cancer Group   Work E.   Bentzen S.M.   Nielsen O.S.   Fode K.   Michalski W.   Palshof T.  

European Journal of Cancer, Vol. 32, Iss. 5, 1996-05 ,pp. : 772-778

Elsevier

Access to resources Recommend Favorite

Small Cell Lung Cancer and Prophylactic Cranial Irradiation (PCI): Perhaps the Question is Not who Needs PCI but who Wants PCI?

By Le Chevalier T.   Arriagada R.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1717-1719

Elsevier

Access to resources Recommend Favorite

Amrubicin: A Synthetic Anthracyclin Analogue in the Treatment of Extensive Stage Small Cell Lung Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 3, 2009-11 ,pp. : 241-245

Bentham Science Publishers

Access to resources Recommend Favorite

Neurotoxicity due to prophylactic cranial irradiation for smallcell lung cancer: A retrospective analysis

By              

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1048-1052

Science Publishers

Access to resources Recommend Favorite

Amrubicin for treating elderly and poor-risk patients with small-cell lung cancer

By Igawa Satoshi   Ryuge Shinichiro   Fukui Tomoya   Otani Sakiko   Kimura Yuka   Katono Ken   Takakura Akira   Kubota Masaru   Mitsufuji Hisashi   Katagiri Masato   Yanase Nobuo   Masuda Noriyuki  

International Journal of Clinical Oncology, Vol. 15, Iss. 5, 2010-10 ,pp. : 447-452

Springer Publishing Company

Access to resources Recommend Favorite